Earnings Feed
Start Free
Home/Filings/4/A/0001179110-17-015779
4/A//SEC Filing

BARROWS CRAIG 4/A

Accession 0001179110-17-015779

CIK 0000855654other
View on SEC.govCompany Profile

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 3:07 PM ET

Size

13.4 KB

Accession

0001179110-17-015779

Insider Transaction Report

Form 4/AAmended
Period: 2017-09-13
IMMUNOGEN INCIMGN
BARROWS CRAIG
Vice-President,General Counsel
Transactions
  • Sale

    Common Stock

    2017-09-13$6.95/sh−14,600$101,404→ 176,900 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-09-15$4.50/sh−30,000$135,000→ 0 total
    Exercise: $4.50From: 2008-10-03Exp: 2017-10-03→ Common Stock (30,000 underlying)
  • Exercise/Conversion

    Common Stock

    2017-09-13$4.50/sh+20,000$90,000→ 191,500 total
  • Sale

    Common Stock

    2017-09-15$6.73/sh−22,450$151,053→ 184,450 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2017-09-13$4.50/sh−20,000$90,000→ 30,000 total
    Exercise: $4.50From: 2008-10-03Exp: 2017-10-03→ Common Stock (20,000 underlying)
  • Exercise/Conversion

    Common Stock

    2017-09-15$4.50/sh+30,000$135,000→ 206,900 total
Footnotes (3)
  • [F1]Exercisable as to 12,500 shares commencing on October 3, 2008, 12,500 shares commencing on October 3, 2009, 12,500 shares commencing on October 3, 2010 and 12,500 shares commencing on October 3, 2011.
  • [F2]Weighted average price of shares sold.
  • [F3]This amendment to Form 4 is being filed to correct the total shares held to include restricted shares which were inadvertently excluded from the totals in the original Form 4 filed on September 15, 2017.

Documents

1 file

Issuer

IMMUNOGEN INC

CIK 0000855654

→
Entity typeother

Related Parties

1
  • filerCIK 0001177813

Filing Metadata

Form type
4/A
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 3:07 PM ET
Size
13.4 KB
View on SEC.gov